Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126292921 | 12629292 | 1 | I | 20130718 | 20160808 | 20160808 | EXP | US-RANBAXY-2013US-71810 | RANBAXY | CROSBY D, PETERSON J, CARROLL BT. ATYPICAL NEUROLEPTIC MALIGNANT SYNDROME IN H1N1 PNEUMONIA. ANN CLIN PSYCHIATRY. 2013;FEB;25(1):69-70 | 60.00 | YR | M | Y | 0.00000 | 20160808 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126292921 | 12629292 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 20 MG, DAILY | Y | N | 91038 | 20 | MG | ||||||
| 126292921 | 12629292 | 2 | SS | HALOPERIDOL DECANOATE. | HALOPERIDOL DECANOATE | 1 | Intramuscular | 200 MG, EVERY 4 WEEKS | U | 0 | 200 | MG | INJECTION | /month | |||||
| 126292921 | 12629292 | 3 | C | DIVALPROEX SODIUM. | DIVALPROEX SODIUM | 1 | Unknown | 2000 MG, DAILY | U | 0 | 2000 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126292921 | 12629292 | 1 | Product used for unknown indication |
| 126292921 | 12629292 | 2 | Product used for unknown indication |
| 126292921 | 12629292 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126292921 | 12629292 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126292921 | 12629292 | Blood creatine phosphokinase increased | |
| 126292921 | 12629292 | Confusional state | |
| 126292921 | 12629292 | Liver function test increased | |
| 126292921 | 12629292 | Mental status changes | |
| 126292921 | 12629292 | Neuroleptic malignant syndrome | |
| 126292921 | 12629292 | Pyrexia | |
| 126292921 | 12629292 | Stupor | |
| 126292921 | 12629292 | Tachycardia | |
| 126292921 | 12629292 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |